Alcon(ALC)
Focus: Alcon is a public ophthalmology-focused company headquartered in Fort Worth, TX, with a diversified portfolio spanning eye-care pharmaceuticals, surgical devices, and contact lens solutions. The company generates 43% of revenue from its flagship glaucoma treatment RHOPRESSA.
Profile data last refreshed 18h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
352+229 this month
Hot — 541 jobs added in 30d
Net +229 (541 new, 312 removed). Aggressive expansion phase.
Should You Work at Alcon?
AI assessmentAlcon offers career stability in a well-established ophthalmology franchise but with limited growth runway and thin early-stage innovation; best suited for professionals seeking steady-state roles in peak-cycle commercialization or device/diagnostics rather than drug discovery.
Why Work Here
- Dominant position in ophthalmology with two peak-revenue glaucoma drugs (RHOPRESSA and ROCKLATAN) generating $321M in combined Part D spending, providing stable cash flows and R&D funding.
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
1 in 5yr
SIMBRINZA
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$175M Part DStable
Peak7.5yr
Flagship product representing 43% of company revenue; drives profitability and funds R&D pipeline through 2034 exclusivity.
Help build intelligence for Alcon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.